Abstract
The benefits and problems associated with the use of continuous cell lines (CCLs) for the production of various types of biological products have been discussed many times during the past few years (1, 2, 10). The purpose of this paper is to review past major events and more recent results which have led to the widening use of CCLs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beale AJ: Choice of cell substrate for biological products. Adv. Exp. Biol. Med. 118, 83–97, 1979.
Hayflick L, Plotkin S, and Stevenson RE: History of the acceptance of human diploid cell strains as substrates for human virus vaccine production. Develop. Biol. Standard. 68, 1987.
Hilleman MR: Cell line saga: an argument in favor of production of biologicals in cancer cells. Adv. Exp. Biol. Med. 118, 47–58, 1979.
Hopps HE and Petricciani JC (eds.): Abnormal Cells, New Products, and Risk. Tissue Culture Association, Gaithersburg, MD, 1985.
Lowy DR: Potential hazards from contaminating DNA that contains oncogenes. In: Abnormal Cells, New Products, and Risk (HE Hopps and JC Petricciani, eds.) pp 36–40, Tissue Culture Association, Gaithersburg, MD, 1985.
Perkins FT and Hennessen W (eds.): Use of Heteroploid and Other Cell Substrates for the Production of Biologicals. Karger, Basel 1982
Petricciani JC, Hopps HE and Chapple PH (eds.): Cell Substrates. Plenum, New York, 1979.
Petricciani JC and Regan PJ: Risk of neoplastic transformation from cellular DNA: calculations using the oncogene model. Develop. Biol. Standard. 68, 1987.
Salk J: The spector of malignancy and criteria for cell lines as substrates for vaccines. Adv. Exp. Biol. Med. 118, 107–113, 1979.
Tam JP: Physiological effects of transforming growth factor in the newborn mouse. Science 229, 673–675, 1985.
Wahl G: Detection of adventitious agents and sensitivity of methods. In: Abnormal Cells, New Products, and Risk (HE Hopps and JC Petricciani, eds.) pp 50–56, Tissue Culture Association, Gaithersburg, MD, 1985.
World Health Organization Technical Report Series, No. 747: Report of the WHO study group on biologicals: Acceptability of cell substrates for production of biologicals, Geneva, 1987.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Petricciani, J.C. (1989). Use of Cell Lines in Biotechnology. In: Miller, A.O.A. (eds) Advanced Research on Animal Cell Technology. NATO ASI Series, vol 156. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0875-8_5
Download citation
DOI: https://doi.org/10.1007/978-94-009-0875-8_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6881-9
Online ISBN: 978-94-009-0875-8
eBook Packages: Springer Book Archive